Trial · NCT00193856
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
NCT00193856, Phase 3, Completed, Trans Tasman Radiation Oncology Group
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. RADAR Trial - Randomised Androgen Deprivation and Radiotherapy. Trials, record NCT00193856. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00193856
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
- NCT number
- NCT00193856
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 1,071 participants, actual
- Lead sponsor
- Trans Tasman Radiation Oncology Group
- Conditions
- Prostate Cancer
- Interventions
- Leuprorelin Acetate, Zoledronic Acid, Conventional external beam therapy
- First posted
- 2005-09-19
- Last updated
- 2017-10-12
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Prostate cancer-specific mortality. | Two main endpoint analyses are planned when 6.5 and 10 years have elapsed from randomisation of the last participant | |
| Secondary | Cumulative incidence of PSA progression | Two main endpoint analyses are planned when 6.5 and 10 years have elapsed from randomisation of the last participant | |
| Secondary | Cumulative incidence of local, distant and bony progression and associated patterns of clinical progression | Two main endpoint analyses are planned when 6.5 and 10 years have elapsed from randomisation of the last participant | |
| Secondary | All-cause mortality | Two main endpoint analyses are planned when 6.5 and 10 years have elapsed from randomisation of the last participant | |
| Secondary | Changes in bone mineral density and osteopenic fracture | One endpoint analysis is planned when 4.5 years have elapsed from randomisation of the last participant | |
| Secondary | Quality of life assessment | One endpoint analysis is planned when 3 years have elapsed from randomisation of the last participant | |
| Secondary | Treatment related morbidity | One endpoint analysis is planned when 4 years have elapsed from randomisation of the last participant | |
| Secondary | Cumulative incidence of secondary therapeutic intervention | Two main endpoint analyses are planned when 6.5 and 10 years have elapsed from randomization of the last participant |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00193856
GET https://conductscience.org/api/trials/v1/NCT00193856/registered